The latest price target for Instil Bio (NASDAQ:TIL) was reported by HC Wainwright & Co. on November 18, 2024. The analyst firm set a price target for $110.00 expecting TIL to rise to within 12 months (a possible 429.36% upside). 17 analyst firms have reported ratings in the last year.

The latest analyst rating for Instil Bio (NASDAQ:TIL) was provided by HC Wainwright & Co., and Instil Bio reiterated their buy rating.

There is no last upgrade for Instil Bio

The last downgrade for Instil Bio Inc happened on April 12, 2024 when Jefferies changed their price target from $5 to $11 for Instil Bio Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Instil Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Instil Bio was filed on November 18, 2024 so you should expect the next rating to be made available sometime around November 18, 2025.

While ratings are subjective and will change, the latest Instil Bio (TIL) rating was a reiterated with a price target of $110.00 to $110.00. The current price Instil Bio (TIL) is trading at is $20.78, which is out of the analyst’s predicted range.